Where is the Place of Surgery for N2 Disease?

被引：0
|
作者：
Van Schil, Paul [1 ]
Faivre-Finn, Corinne [2 ,3 ]
机构：
[1] Antwerp Univ Hosp, Thorac & Vasc Surg, Antwerp, Belgium
[2] Univ Manchester, Radiotherapy Res Related, Manchester, Lancs, England
[3] Christie NHS Fdn Trust, Manchester, Lancs, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
induction therapy; Chemo-radiotherapy; Surgery; stage IIIA-N2 disease; CELL LUNG-CANCER; SALVAGE SURGERY; RADIOTHERAPY; CHEMOTHERAPY; GUIDELINES;
D O I：
10.1016/j.jtho.2016.11.138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MTE05.01
引用
收藏
页码：S152 / S154
页数：3
相关论文
共 50 条
  • [11] The Role of Mediastinoscopy in Induction Therapy of N2 NSCLC
    Call, Sergi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S73 - S74
  • [12] Mediastinoscopic Assessment of N2 Disease and Optimisation of Surgical Treatment of N2 Disease in NSCLC
    Karimundackal, G.
    Patil, V.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S858 - S858
  • [13] COUNTERPOINT: Is N2 Disease a Contraindication for Surgical Resection for Superior Sulcus Tumors? No
    Li, Wilson W.
    Burgers, Jacobus A.
    Klomp, Houke M.
    Hartemink, Koen J.
    CHEST, 2015, 148 (06) : 1375 - 1379
  • [14] Multimodality Treatment including Surgery Related to the Type of N2 Involvement in Locally Advanced Non-Small Cell Lung Cancer
    Allaeys, Toon
    Berzenji, Lawek
    Lauwers, Patrick
    Yogeswaran, Suresh Krishan
    Hendriks, Jeroen M. H.
    Billiet, Charlotte
    De Bondt, Charlotte
    Van Schil, Paul E.
    CANCERS, 2022, 14 (07)
  • [15] The Importance of Mediastinal Down-Staging During Induction Therapy of N2 Disease
    De Leyn, Paul
    Decaluwe, Herbert
    Dooms, Christophe
    Vansteenkiste, Johan
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S71 - S72
  • [16] What is Resectable N2 Disease, and What is Unresectable N2 Disease: A Medical Oncologist's Viewpoint
    Horinouchi, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1718 - S1719
  • [17] Minimal invasive surgery in locally advanced N2 non-small cell lung cancer
    Patane, Ana Karina
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 519 - 528
  • [18] Current Readings: Management of N2 Disease for Lung Cancer
    Wigle, Dennis A.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2014, 26 (01) : 67 - 70
  • [19] Commentary: The Benefit of Surgery for Stage III N2 Positive Non-Small Cell Lung Cancer is Independent of Where the Okies Go
    Abbas, Abbas E.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2022, 34 (01) : 309 - 310
  • [20] Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease
    Kim, Hong Kwan
    Cho, Jong Ho
    Choi, Yong Soo
    Zo, Jae Ill
    Shim, Young Mog
    Park, Keunchil
    Ahn, Myung-Ju
    Ahn, Yong Chan
    Kim, Kwhanmien
    Kim, Jhingook
    LUNG CANCER, 2016, 96 : 56 - 62
12345